Interferon-β Theraphy in Multiple Sclerosis Patients: is Response Age Dependent?

Journal Title: Journal of Neurological Sciences-Turkish - Year 2009, Vol 26, Issue 2

Abstract

The onset of Multiple sclerosis (MS) is usually between 20 and 40 years and in those patients, β -interferons reduce relapse frequency in a rate of 30%. The purpose of this study was to compare the therapeutical response to IFNβ in young versus older MS patients. Multiple sclerosis patients with onset of symptoms older 40 were described as older age-onset MS (OAOMS) and the patients with onset of symptoms lower than 20 years were described as a young-onset MS (YOMS). Eighty-five YOMS patients and 22 OAOMS patients were enrolled from 1997 to 2007 and medical records for each patient were reviewed. Individuals with relapse rates of more than 1/year, who fail in reducing their attack rates and/or deterioration of disability, were described as evidence for lack of therapeutic response. In the YOMS group, 70,6% of patients were responder. This ratio were 59% in OAOMS group with no statistically difference. Female to male ratio was 2.15:1 in young patients and 3.4:1 in older patients. Older MS patients had a higher EDSS score at initiation of IFNβ therapy. In responder patients, female to male ratio was higher for older age onset patients (12/13 vs 36/60) (p<0.05). Of nonresponder patients, female to male ratio was lower for older age onset patients (5/4 vs 22/3) (p<0.05). Although progressive form of the disease is more common in late onset MS, literature is limited for the effect of onset age on IFN response. In this study, the response to IFN therapy in young onset MS patients has been found similar to older age onset MS patients.

Authors and Affiliations

Asli KURNE, Murat TERZI, Omer AYDIN, Musa ONAR, Rana KARABUDAK

Keywords

Related Articles

Tuberoskleroz Kompleksi ve Otizm

Giriş: Tuberoskleroz göz, deri, beyin, kalp ve böbrekler gibi çok sayıda organı tutabilen, anormal doku büyümeleri sonucu iyi huylu tümörler, hamartomlar ile seyreden, sıkça görülen, otozomal dominant geçişli kalıtsal bi...

Spontaneous Regression of Lumbar Disc Herniation: Report of Two Cases

Spontaneous disc regression is described in lumbar, thoracic, cervical regions and also in various clinical situations. Although, spontaneous regression of lumbar disc herniation is a well defined clinical situation, the...

Genetical and Histological Investigation of Turkish Siblings With Spina Bifida Occulta Who Had Neurosurgical Intervention

Spina bifida is the one of the most frequently occurring birth defects. More children have spina bifida than muscular dystrophy, multiple sclerosis, and cystic fibrosis combined. Occulta present type is a mild very commo...

Akut İskemik Strokta Akut Faz Reaktanlarının Rolü

İskemik strok patogenezinde inflamatuar faktörler önemli rol oynar. Bu çalışmada, akut iskemik strokta fibrinojen, C-reaktif protein ve diğer akut faz reaktanlarının düzeylerini saptamayı amaçladık. Çalışmaya 43 hasta da...

Langerhans Cell Histiocytosis and Intracranial Germinoma: Are Immunohistology Techniques Helpful in Distinguishing Two Entities?

Langerhans cell histiocytosis (LCH) is a clonal proliferative disease of the Langerhans cell. Langerhans cell bears abundant eosinophilic cytoplasm mainly associated with a matrix rich in eosinophils, mononuclear and mul...

Download PDF file
  • EP ID EP118673
  • DOI -
  • Views 107
  • Downloads 0

How To Cite

Asli KURNE, Murat TERZI, Omer AYDIN, Musa ONAR, Rana KARABUDAK (2009). Interferon-β Theraphy in Multiple Sclerosis Patients: is Response Age Dependent?. Journal of Neurological Sciences-Turkish, 26(2), 131-138. https://europub.co.uk/articles/-A-118673